Octyl_gallate
CAS 1034-01-1
Octyl_gallate (CAS 1034-01-1) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 125 ug.mL-1 | 25 | - |
| - | IC50 | 29736.75 nM | 19 | - |
| - | Potency | 34884.025 nM | 4 | - |
| - | EC50 | 2000 nM | 2 | - |
| - | IC50 | 19 ppm | 1 | - |
| - | Ki | 700 nM | 1 | - |
| - | MIC | 210000 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Octyl_gallate used for in pharmaceutical contexts?
Octyl_gallate (CAS 1034-01-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Octyl_gallate?
No adverse-event association or SIDER side-effect rows are rendered for Octyl_gallate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Octyl_gallate also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Caprylyl Gallate with EU status "permitted".
What clinical phase is Octyl_gallate in?
No phase 1-4 clinical development badge is rendered for Octyl_gallate because the matched compound identifier rows do not contain a max-phase value.